Planta Med 2015; 81(04): 259-271
DOI: 10.1055/s-0034-1396313
Reviews
Georg Thieme Verlag KG Stuttgart · New York

Prospects of Boswellic Acids as Potential Pharmaceutics

Zhiyong Du*
1  Institution of Basic Theory, China Academy of Chinese Medical Sciences, Beijing, China
,
Zhenli Liu*
1  Institution of Basic Theory, China Academy of Chinese Medical Sciences, Beijing, China
,
Zhangchi Ning
2  School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing Municipal Key Laboratory for Basic Research of Chinese Medicine, Beijing, China
,
Yuanyan Liu
2  School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing Municipal Key Laboratory for Basic Research of Chinese Medicine, Beijing, China
,
Zhiqian Song
1  Institution of Basic Theory, China Academy of Chinese Medical Sciences, Beijing, China
,
Chun Wang
1  Institution of Basic Theory, China Academy of Chinese Medical Sciences, Beijing, China
,
Aiping Lu
3  Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China
4  School of Chinese Medicine, Hong Kong Baptist University, Kowloon Tong, Hong Kong SAR, China
› Author Affiliations
Further Information

Publication History

received 03 June 2014
revised 22 October 2014

accepted 07 January 2015

Publication Date:
25 February 2015 (eFirst)

Abstract

Boswellic acids have long been considered the main bioactive components of frankincense, and many studies in vitro and in animals as well as several clinical studies have confirmed their various bioactivities. In particular, a large number of mechanistic studies have confirmed their anti-inflammatory and antitumor activities. However, not every boswellic acid exhibits a satisfactory pharmacological performance, which depends on the chemical structure and functional groups of the acid. To enhance the pharmacological values of boswellic acids, derivatization has been specifically applied with the aim of discovering more active derivatives of BAs. In addition, the preliminary pharmacokinetic studies of these compounds using various standard methods show their poor bioavailability in humans and rodents, which has led to questions of their pharmacological relevance and potentially limits their use in clinical practice and pharmaceutical development. To improve these effects, some approaches have shown some improvements in effectiveness, and the new formula compatibility approach is considered a very reasonable method for improving the bioavailability of boswellic acids.

* These authors contributed equally to this work.